Tag: sotorasib panitumumab FDA approval

Home / sotorasib panitumumab FDA approval

Categories

Sotorasib with panitumumab is approved by the USFDA for KRAS G12C-mutated colorectal cancer

On January 16, 2025, the Food and Drug Administration sanctioned the use of sotorasib (Lumakras, Amgen Inc.) in conjunction with panitumumab (Vectibix, Amgen Inc.) for adult patients diagnosed with KR...
sotorasib-panitumumab-fda-approval

We Are Online! Chat With Us!
Scan the code